Thursday Morning Links

This and that for your Thursday reading.

- Steven Levitsky, Lucan Way and Daniel Ziblatt discuss how the Trump regime has used the power of an authoritarian state to impose costs on any opposition - and how it's nonetheless essential for people to resist rather than going along to get along. Robert Reich writes about the need to build a populist progressive movement to ensure people know there's a viable alternative to Trump's corruption and corporatism. And John Baglow's review of new books by Alex Himelfarb and Denise Hearn/Vass Bednar examines how neoliberalism has come to dominate our economic and social foundation - and the difficulty countering the power of capital in trying to make change.

- Attracta Mooney reports on new data showing that global warming has exceeded the 1.5 Celsius threshold for nearly all of the past two years. And Andreas Sieber and Stela Herschmann discuss the futility of holding climate talks while skirting any discussion of the fossil fuels which are the cause of three quarters of greenhouse gas emissions.  

- Isaac Sevier and Winston Yau write about the impending summer of shutoffs as outdated infrastructure and worsening extreme weather events make it inevitable that dirty energy sources will shut down. Euronews Green examines new polling showing that Europeans recognize the need to transition to clean and secure energy sources rather than relying on fossil fuel imports. And Eleni Courea reports on England's requirement for solar panels on new homes as a key example of the transition in progress. 

- Mariah Blake discusses how untested synthetic materials came to be so ubiquitous as a long-term consequence of a corporate PR campaign. 

- Finally, Brint Milward examines how the hollowing-out of the U.S.' federal government will have disastrous effects on state- and local-level services linked to what DOGE is destroying. David Armstrong reports on how a cancer drug which can be produced for 25 cents per pill is being sold for 4,000 times that cost, resulting in people being unable to afford the treatment they need.